RoscoPharm ApS: Financial statements 2024
CVR: 43431102
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
RoscoPharm ApS (CVR 43431102) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 30,344 and a net result of DKK -12,606. Equity in the 2024 report amounted to DKK 0.
- Gross Profit
- DKK 30,344
- Profit/Loss
- DKK -12,606
- Equity
- DKK 0
- Total Assets
- DKK 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
RoscoPharm ApS has published its interim report for the period August 2, 2022 – December 31, 2023.
About RoscoPharm ApS
RoscoPharm ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2022. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Peter Reumert. The company is owned by Holdingselskabet 10. maj ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -12,606 the year before. Equity in the 2025 report amounted to DKK 0.